摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

p-nitrophenyl 4-amino-4-deoxy-N10-formylpteroate | 95485-01-1

中文名称
——
中文别名
——
英文名称
p-nitrophenyl 4-amino-4-deoxy-N10-formylpteroate
英文别名
p-nitrophenyl 4-deoxy-4-amino-N10-formylpteroate;p-nitrophenyl 4-amino-4-deoxy-(10)N-formylpteroate;(4-Nitrophenyl) 4-[(2,4-diaminopteridin-6-yl)methyl-formylamino]benzoate
p-nitrophenyl 4-amino-4-deoxy-N<sup>10</sup>-formylpteroate化学式
CAS
95485-01-1
化学式
C21H16N8O5
mdl
——
分子量
460.409
InChiKey
XLLHSDWSXBTPNT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    836.7±75.0 °C(Predicted)
  • 密度:
    1.575±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    34
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.05
  • 拓扑面积:
    196
  • 氢给体数:
    2
  • 氢受体数:
    11

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    甲氨蝶呤类似物。26.通过含有碱性氨基酸侧链的甲氨蝶呤和氨基蝶呤类似物抑制二氢叶酸还原酶和叶酰聚谷氨酸合成酶的活性以及体外肿瘤细胞的生长。
    摘要:
    合成了抗肿瘤抗叶酸甲氨蝶呤(MTX)的类似物,其中谷氨酸(Glu)部分被鸟氨酸(Orn),2,4-二氨基丁酸(Dab)或2,3-二氨基丙酸(Dap)代替。还合成了以Orn代替Glu的氨基蝶呤(AMT)类似物。MTX类似物是通过在氨基氰基磷酸二乙酯存在下,使4-氨基-4-脱氧-N10-甲基蝶酸(mAPA)与N-ω-Boc-α,ω-二氨基链烷酸反应,然后用三氟乙酸(TFA)脱保护而获得的。 )或通过对硝基苯基-mAPA与Nω-Boc-α,ω-二氨基链烷酸反应并随后用TFA处理。AMT类似物(APA-Orn)是通过在55°C下于55°C下使对硝基苯基4-氨基-4-脱氧-N10-甲酰基蝶酸酯与甲硅烷基化的Nδ-Boc-L-鸟氨酸反应3天(产率为45%) ),皂化(83%)和TFA裂解(89%)。APA-Orn是来自L1210小鼠白血病的二氢叶酸还原酶(DHFR)(IC50 = 0.072 micr
    DOI:
    10.1021/jm00155a012
  • 作为产物:
    描述:
    6-溴乙基-喋啶-2,4-二胺乙酸酐三乙胺 、 barium(II) oxide 作用下, 以 N,N-二甲基乙酰胺N,N-二甲基甲酰胺 为溶剂, 反应 44.5h, 生成 p-nitrophenyl 4-amino-4-deoxy-N10-formylpteroate
    参考文献:
    名称:
    Methotrexate Analogues. 25. Chemical and Biological Studies on the γ-tert-Butyl Esters of Methotrexate and Aminopterin
    摘要:
    gamma-tert-Butylaminopterin (gamma-tBAMT), the first example of an aminopterin (AMT) gamma-monoester, was synthesized, and new routes to the known N10-methyl analogue gamma-tert-butyl methotrexate (gamma-tBMTX) were developed. The inhibitory effects of gamma-tBAMT on the activity of purified dihydrofolate reductase (DHFR) from L1210 murine leukemia cells, the growth of L1210 cells and CEM human leukemic lymphoblasts in suspension culture, and the growth of several lines of human squamous cell carcinoma of the head and neck in monolayer culture were compared with the effects of gamma-tBMTX and the parent acids AMT and methotrexate (MTX). Patterns of cross-resistance to gamma-tBAMT, gamma-tBMTX, and AMT among several MTX-resistant cell lines were examined. In vivo antitumor activities of gamma-tBAMT and gamma-tBMTX were compared in mice with L1210 leukemia. While the activity of gamma-tBAMT was very close to that of gamma-tBMTX in the DHFR inhibition assay, the AMT ester was more potent than the MTX ester against cells in culture and against L1210 leukemia in vivo. Only partial cross-resistance was shown against gamma-tBMTX and gamma-tBAMT in cultured cells that were resistant to MTX by virtue of a transport defect or a combination of defective transport and elevated DHFR activity.
    DOI:
    10.1021/jm50001a021
点击查看最新优质反应信息

文献信息

  • Methotrexate analog. 32. Chain extension, .alpha.-carboxyl deletion, and .gamma. carboxyl replacement by sulfonate and phosphate. Effect on enzyme binding and cell-growth inhibition
    作者:Andre Rosowsky、Ronald A. Forsch、Richard G. Moran、William Kohler、James H. Freisheim
    DOI:10.1021/jm00402a012
    日期:1988.7
    acid side chains in place of glutamate were synthesized and tested as inhibitors of folylpolyglutamate synthetase (FPGS) from mouse liver. The aminophosphonoalkanoic acid analogues were also tested as inhibitors of dihydrofolate reductase (DHFR) from L1210 murine leukemia cells and as inhibitors of the growth of MTX-sensitive (L1210) and MTX-resistant (L1210/R81) cells in culture. The optimal number
    合成了甲氨蝶呤MTX)和氨基蝶呤AMT)与氨基膦酸侧链,基链烷磺酸基链烷膦酸侧链代替谷酸的类似物,并作为小鼠肝脏叶酰聚谷酸合成酶(FPGS)的抑制剂进行了测试。还测试了氨基膦酸链烷酸类似物作为L1210鼠白血病细胞中二氢叶酸还原酶(DHFR)的抑制剂,以及培养中MTX敏感(L1210)和MTX耐药(L1210 / R81)细胞生长的抑制剂。发现AMT基膦酰基链烷酸类似物中的CH 2基团的最佳数目对于酶抑制和细胞生长抑制都是两个,但是对于对抗FPGS的活性尤其关键。与先前研究的高半胱酸和2-基-4-膦酰基丁酸类似物相比,α-羧基的缺失也导致抗-FPGS活性降低。在没有α-羧基的MTX的基链烷磺酸类似物中,由于羧酰胺和磺酸酯部分之间的CH2基团数量从一变为四个,因此抗FPGS活性较低,并且变化很小。在类似的MTX烷烃膦酸类似物中,抗FPGS活性也很低,在羧酰胺和膦酸
  • Methotrexate analogs. 34. Replacement of the glutamate moiety in methotrexate and aminopterin by long-chain 2-aminoalkanedioic acids
    作者:Andre Rosowsky、Henry Bader、William Kohler、James H. Freisheim、Richard G. Moran
    DOI:10.1021/jm00402a014
    日期:1988.7
    Eight previously unreported methotrexate (MTX) and aminopterin (AMT) analogues with the L-glutamate moiety replaced by DL-2-aminoalkanedioic acids containing up to 10 CH2 groups were synthesized from 4-amino-4-deoxy-N10-methylpteroic or 4-amino-4-deoxy-N10-formylpteroic acid. All the compounds were potent inhibitors of purified L1210 mouse leukemia dihydrofolate reductase (DHFR), with IC50's of 0.023-0
    从4-基-4-脱氧-N10-甲基蝶呤或4-基-4-合成了八个以前未报告的甲氨蝶呤MTX)和氨基蝶呤AMT)类似物,其中L-谷氨酸部分被DL-2-基链烷二酸所取代,该DL-2-基链烷二酸含有多达10个CH2基团。基-4-脱氧-N10-甲酰基蝶酸。所有化合物都是纯化的L1210小鼠白血病二氢叶酸还原酶(DHFR)的有效抑制剂MTX类似物的IC50为0.023-0.034 microM,AMT类似物的IC50为0.054-0.067 microM。该化合物不是部分纯化的小鼠肝叶酰聚谷酸合成酶(FPGS)的底物,而是它们的抑制剂。活性与侧链中CH 2基团的数量相关。链增长的MTX类似物对培养物中细胞生长的抑制作用的IC50为0.016-0.64 microM(针对CEM人白血病淋巴母细胞)和0。针对L1210小鼠白血病细胞的0012-0.026 microM。但是,抑制生长的最佳
  • Methotrexate analogs. 28. Synthesis and biological evaluation of new .gamma.-monoamides of aminopterin and methotrexate
    作者:Andre Rosowsky、Henry Bader、Mary Radike-Smith、Carol A. Cucchi、Michael M. Wick、James H. Freisheim
    DOI:10.1021/jm00159a023
    日期:1986.9
    Lipophilic gamma-monoamide derivatives of aminopterin (AMT) were synthesized in high overall yield from 4-amino-4-deoxy-N10-formylpteroic acid and gamma-N-tert-alkyl-, gamma-N-aralkyl-, or gamma-N-arylamides of alpha-benzyl L-glutamate via a modification of the mixed carboxylic-carbonic anhydride coupling method. Coupling was also accomplished with p-nitrophenyl 4-amino-4-deoxy-N10-formylpteroate. Compounds obtained in this manner included the gamma-tert-butylamide, gamma-(1-adamantylamide), gamma-benzylamide, gamma-(3,4-dichlorobenzylamide), gamma-(2,6-dichlorobenzylamide), gamma-anilide, gamma-(3,4-methylenedioxyanilide), and gamma-(3,4-dihydroxanilide) derivatives of AMT. Also prepared, from 4-amino-4-deoxy-N10-methylpteroic acid via diethyl phosphorocyanidate coupling, was the gamma-(3,4-methylenedioxyanilide) of MTX. The methylenedioxyanilides were cleaved smoothly to dihydroxyanilides with boron tris(trifluoroacetate) in trifluoroacetic acid. All the gamma-monoamides were tested as inhibitors of purified dihydrofolate reductase (DHFR) from murine L1210 leukemia cells and as inhibitors of the growth of wild-type L1210 cells and a subline (L1210/R81) with high-level resistance to MTX and AMT based mainly on a defect in drug uptake via active transport. Several compounds were also tested against human leukemic lymphoblasts (CEM cells) and a resistant subline (CEM/MTX) whose resistance is likewise based on uptake. The IC50 of the gamma-monoamides against DHFR was 1.5- to 5-fold higher than that of the parent acids, but the IC50 against cultured cells varied over a much broader range, suggesting that uptake and/or metabolism rather than DHFR binding are principal determinants of in vitro growth inhibitory activity for these compounds. gamma-N-Aryl and gamma-N-aralkyl derivatives appeared to be more potent than gamma-N-tert-alkyl derivatives. Where comparison could be made, AMT gamma-monoamides were more potent than MTX gamma-monoamides. Several of the gamma-monoamides showed potency comparable to that of the parent acid against wild-type L1210 and CEM cells; all of them were more potent than MTX against the L1210/R81 subline; and some of the AMT gamma-monoamides were also more potent than the parent acid against resistant CEM/MTX cells. As a group, however, the gamma-monoamides were considerably more active against the murine cells than against the human cells, suggesting that the former may take up the amides better or may be able to metabolize them more efficiently than the parent acids. All the gamma-monoamides were tested in vivo against L1210 leukemia in mice.(ABSTRACT TRUNCATED AT 400 WORDS)
  • ROSOWSKY, ANDRE;FORSCH, RONALD A.;MORAN, RICHARD G.;KOHLER, WILLIAM;FREIS+, J. MED. CHEM., 31,(1988) N 7, 1326-1331
    作者:ROSOWSKY, ANDRE、FORSCH, RONALD A.、MORAN, RICHARD G.、KOHLER, WILLIAM、FREIS+
    DOI:——
    日期:——
  • ROSOWSKY, ANDRE;BADER, HENRY;KOHLER, WILLIAM;FREISHEIM, JAMES H.;MORAN, R+, J. MED. CHEM., 31,(1988) N 7, 1338-1344
    作者:ROSOWSKY, ANDRE、BADER, HENRY、KOHLER, WILLIAM、FREISHEIM, JAMES H.、MORAN, R+
    DOI:——
    日期:——
查看更多

同类化合物

非那米柳 雷尼替丁 降钙素(humanreduced),8-L-缬氨酸-(9CI) 间苯甲酰氧基苯乙酮 间苯二甲酸二苯酯 间甲苯基苯甲酸酯 间双没食子酸 醋氨沙洛 邻苯二甲酸苄酯2-乙己基酯 邻苯二甲酸二苯酯-D4 邻苯二甲酸二苯酯 邻甲苯基苯甲酸酯 邻氨基苯甲酸(4-硝基苯基)酯 邻亚苯基二苯甲酸酯 贝诺酯 袋衣酸 血竭黄烷A 萘-1,5-二磺酸-4-[2-(二甲氨基)乙氧基]-2-甲基-5-(丙烷-2-基)苯基2-氨基苯酸酯(1:1) 茶痂衣酸 苯酚,2-[2-[(4-氯苯基)氨基]-4-噻唑基]-,苯酸酯(ester) 苯甲醯柳酸甲酯 苯甲酸苯酯 苯甲酸五氟苯酯 苯甲酸丁香酚酯 苯甲酸4-[[(4-甲氧基苯基)亚甲基]氨基]苯基酯 苯甲酸4-(乙酰氨基)-2-[[2-[4-(乙酰氨基)苯甲酰基]亚肼基]甲基]苯基酯 苯甲酸2-(2-苯并恶唑基)苯酯 苯甲酸-4-甲基苯酯 苯甲酸-(4-环戊基-苯基酯) 苯甲酸-(2-烯丙基-4-溴-苯基酯) 苯甲酸-(2-溴-4,6-二硝基-苯基酯) 苯甲酸-(2,4-二溴-3-甲基-苯基酯) 苯甲酸-(2,4-二氯-5-甲基-苯基酯) 苯甲酸-(2,4-二叔丁基苯基酯) 苯甲酸,4-羟基-,4-[(4-羟基苯氧基)羰基]苯基酯 苯甲酸,4-羟基-,4-(己氧基)苯基酯 苯甲酸,4-羟基-,4-(十四烷氧基)苯基酯 苯甲酸,4-羟基-,4-(十二烷氧基)苯基酯 苯甲酸,4-甲酰基-,4-(辛氧基)苯基酯 苯甲酸,4-甲氧基-,2-甲酰基苯基酯 苯甲酸,4-甲基-,4-甲基苯基酯 苯甲酸,4-戊基-,4-(壬氧基)苯基酯 苯甲酸,4-丁氧基-,1,4-亚苯基酯 苯甲酸,4-[[[3-[(2,2-二甲基-1-羰基丙氧基)甲基]-3,4-二氢-2-甲基-4-羰基-6-喹唑啉基]甲基]-2-炔丙基氨基]-,五氟苯基酯 苯甲酸,4-[1-(己氧基)乙基]-,4-(辛氧基)苯基酯 苯甲酸,4-(辛氧基)-,4-[[4-[[(1-甲基庚基)氧代]羰基]苯基]乙炔基]苯基酯 苯甲酸,4-(苯基甲氧基)-,4-(癸氧基)苯基酯 苯甲酸,4-(苯基甲氧基)-,4-(壬氧基)苯基酯 苯甲酸,4-(苯基甲氧基)-,4-(十二烷氧基)苯基酯 苯甲酸,4-(癸氧基)-,4-[氰基[(1-羰基戊基)氧代]甲基]苯基酯,(R)-